Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.

Hong S, Lee JH, Chun EK, Kim KI, Kim JW, Kim SH, Lee YG, Hwang IG, Kim JY, Koh SJ, Ko YH, Shin SH, Woo IS, Kim TY, Baek JY, Kim HJ, Kim HJ, Lee MA, Kwon JH, Hong YS, Ryoo HM, Kim JH.

Oncologist. 2019 Nov 27. pii: theoncologist.2019-0085. doi: 10.1634/theoncologist.2019-0085. [Epub ahead of print]

PMID:
31776181
2.

Expression of EEF1A1 Is Associated with Prognosis of Patients with Colon Adenocarcinoma.

Joung EK, Kim J, Yoon N, Maeng LS, Kim JH, Park S, Kang K, Kim JS, Ahn YH, Ko YH, Byun JH, Hong JH.

J Clin Med. 2019 Nov 7;8(11). pii: E1903. doi: 10.3390/jcm8111903.

3.

Cascaded Wx: A Novel Prognosis-Related Feature Selection Framework in Human Lung Adenocarcinoma Transcriptomes.

Shin B, Park S, Hong JH, An HJ, Chun SH, Kang K, Ahn YH, Ko YH, Kang K.

Front Genet. 2019 Jul 19;10:662. doi: 10.3389/fgene.2019.00662. eCollection 2019.

4.

Prognostic implications of stromal hyaluronic acid protein expression in resected oropharyngeal and oral cavity cancers.

Sun S, Won HS, Hong SA, Hong JH, Jo H, Lee H, Kim O, Lee MA, Ko YH.

Korean J Intern Med. 2019 Jul 29. doi: 10.3904/kjim.2018.203. [Epub ahead of print]

5.

QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.

Kim EJ, Kim JS, Lee S, Lee H, Yoon JS, Hong JH, Chun SH, Sun S, Won HS, Hong SA, Kang K, Jo JY, Choi M, Shin DH, Ahn YH, Ko YH.

Int J Cancer. 2019 Sep 15;145(6):1585-1595. doi: 10.1002/ijc.32372. Epub 2019 May 14.

PMID:
31026342
6.

CheckMate-032 Study: promising efficacy with nivolumab-based immunotherapy in pretreated esophagogastric cancer.

Sun S, Kim JJ, Ko YH.

J Thorac Dis. 2019 Mar;11(Suppl 3):S394-S395. doi: 10.21037/jtd.2018.12.02. No abstract available.

7.

Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.

Kim TM, Ko YH, Ha SJ, Lee HH.

BMC Cancer. 2019 Feb 4;19(1):119. doi: 10.1186/s12885-019-5332-y.

8.

MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas.

Kim JS, Kim EJ, Lee S, Tan X, Liu X, Park S, Kang K, Yoon JS, Ko YH, Kurie JM, Ahn YH.

Exp Mol Med. 2019 Jan 17;51(1):9. doi: 10.1038/s12276-018-0203-1.

9.

Prospective Validation of The Korean Cancer Study Group Geriatric Score (KG)-7, a Novel Geriatric Screening Tool, in Older Patients with Advanced Cancer Undergoing First-line Palliative Chemotherapy.

Kim JW, Kim SH, Lee YG, Hwang IG, Kim JY, Koh SJ, Ko YH, Shin SH, Woo IS, Hong S, Kim TY, Baek JY, Kim HJ, Kim HJ, Lee MA, Kwon JH, Hong YS, Ryoo HM, Lee KH, Kim JH.

Cancer Res Treat. 2019 Jul;51(3):1249-1256. doi: 10.4143/crt.2018.451. Epub 2019 Jan 2.

10.

Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer.

Kim JW, Kim JG, Kang BW, Chung IJ, Hong YS, Kim TY, Song HS, Lee KH, Zang DY, Ko YH, Song EK, Baek JH, Koo DH, Oh SY, Cho H, Lee KW.

Cancer Res Treat. 2019 Jan;51(1):223-239. doi: 10.4143/crt.2018.073. Epub 2018 Oct 19.

11.

Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis.

Lee JS, Won HS, Sun S, Hong JH, Ko YH.

Medicine (Baltimore). 2018 Aug;97(32):e11769. doi: 10.1097/MD.0000000000011769. Review.

12.

RNA variant identification discrepancy among splice-aware alignment algorithms.

Hong JH, Ko YH, Kang K.

PLoS One. 2018 Aug 2;13(8):e0201822. doi: 10.1371/journal.pone.0201822. eCollection 2018.

13.

RNA-seq data of invasive ductal carcinoma and adjacent normal tissues from a Korean patient with breast cancer.

Hong JH, Ko YH, Kang K.

Data Brief. 2018 Mar 21;18:736-739. doi: 10.1016/j.dib.2018.03.079. eCollection 2018 Jun.

14.

Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma.

Lim SM, Cho SH, Hwang IG, Choi JW, Chang H, Ahn MJ, Park KU, Kim JW, Ko YH, Ahn HK, Cho BC, Nam BH, Chun SH, Hong JH, Kwon JH, Choi JG, Kang EJ, Yun T, Lee KW, Kim JH, Kim JS, Lee HW, Kim MK, Jung D, Kim JE, Keam B, Yun HJ, Kim S, Kim HR.

Cancer Res Treat. 2019 Jan;51(1):300-312. doi: 10.4143/crt.2018.012. Epub 2018 May 9.

15.

Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer.

Hong SA, Yoo SH, Lee HH, Sun S, Won HS, Kim O, Ko YH.

BMC Cancer. 2018 May 2;18(1):506. doi: 10.1186/s12885-018-4420-8.

16.

Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective study.

Kim JW, Lee YG, Hwang IG, Song HS, Koh SJ, Ko YH, Shin SH, Woo IS, Hong S, Kim TY, Kim SY, Nam BH, Kim HJ, Kim HJ, Lee MA, Kwon JH, Hong YS, Bae SH, Koo DH, Kim KI, Kim JH.

Br J Cancer. 2018 May;118(9):1169-1175. doi: 10.1038/s41416-018-0037-6. Epub 2018 Mar 26.

17.

Factors associated with treatment interruption in elderly patients with cancer.

Won HS, Sun S, Choi JY, An HJ, Ko YH.

Korean J Intern Med. 2019 Jan;34(1):156-164. doi: 10.3904/kjim.2016.318. Epub 2018 Feb 23.

18.

Circulating Microparticles and Coagulation Profiles in Patients with Advanced Stage Solid Tumors.

Sun S, Lee HK, Kim Y, Lee JH, Won HS, Ko YH, Kim H.

Ann Lab Med. 2018 May;38(3):274-276. doi: 10.3343/alm.2018.38.3.274. No abstract available.

19.

Efficacy and safety of oxycodone/naloxone as add-on therapy to gabapentin or pregabalin for the management of chemotherapy-induced peripheral neuropathy in Korea.

Kim BS, Jin JY, Kwon JH, Woo IS, Ko YH, Park SY, Park HJ, Kang JH.

Asia Pac J Clin Oncol. 2018 Oct;14(5):e448-e454. doi: 10.1111/ajco.12822. Epub 2017 Dec 27.

PMID:
29280313
20.

Gastroenteropancreatic-origin neuroendocrine carcinomas: Three case reports with favorable responses following localized radiotherapy and a review of literature.

Won YG, Seo KJ, Hyeon J, Shin OR, Chang E, Sun S, Won HS, Ko YH, Na SJ, Lee SL, Ku YM, Lee DS.

Medicine (Baltimore). 2017 Dec;96(49):e9009. doi: 10.1097/MD.0000000000009009.

Supplemental Content

Loading ...
Support Center